Andrea Sartore-Bianchi, MD, ASST Great Niguarda Metropolitan Hospital, Milan, Italy, discusses treatment approaches regarding the use of targeted therapies in colorectal cancer, including anti-EGFR and targeting HER2 amplification and KRASG12C mutations. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.